Randomized trial of an adherence programme for clients with HIV

被引:47
作者
Fairley, CK
Levy, R
Rayner, CR
Allardice, K
Costello, K
Thomas, C
McArthur, C
Kong, D
Mijch, A
机构
[1] Melbourne Sexual Hlth Ctr, Melbourne, Vic 3053, Australia
[2] Univ Melbourne, Dept Publ Hlth, Parkville, Vic 3052, Australia
[3] Alfred Hosp, Dept Pharm, Melbourne, Vic, Australia
[4] Monash Univ, Victorian Coll Pharm, Dept Pharm Practice, Clayton, Vic 3168, Australia
[5] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia
关键词
adherence; reminder devices; educational programmes;
D O I
10.1258/095646203322556129
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Our aim was to determine if a comprehensive adherence package improved self reported adherence to antiretroviral therapy. The adherence package included an education programme, individualized planning of regimens, and the opportunity for a patient to choose from a number of adherence aids and reminder devices. A randomized step wedge design was used. Forty-three individuals were randomized to begin the intervention over a five-month period. There was a substantial fall in the number of missed doses reported for the last four days (0.76 to 0.38, P=0.03) and last seven days (1.5 to 0.74, P=0.005) but not for the last 28 days (2.5 to 2.5, P=0.63). There was no statistical difference in the viral load or CD4 lymphocyte count in the period before or after the intervention. The Morisky score during the pre and post intervention periods was significantly different (P=0.006), 2.9 (SD 0.9) and 3.3 (SD 0.8) respectively. This adherence package improved self reported adherence during the last four and seven days.
引用
收藏
页码:805 / 809
页数:5
相关论文
共 13 条
[1]  
COLLIER AC, 2002, 9 C RETR OPP INF SEA
[2]   HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: Response to both initial and salvage therapy [J].
Deeks, SG ;
Hecht, FM ;
Swanson, M ;
Elbeik, T ;
Loftus, R ;
Cohen, PT ;
Grant, RM .
AIDS, 1999, 13 (06) :F35-F43
[3]  
Esch L. D., 1999, Recent Research Developments in Antimicrobial Agents and Chemotherapy, V3, P483
[4]   Participation in research and access to experimental treatments by HIV-infected patients [J].
Gifford, AL ;
Cunningham, WE ;
Heslin, KC ;
Andersen, RM ;
Nakazono, T ;
Lieu, DK ;
Shapiro, MF ;
Bozzette, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (18) :1373-1382
[5]  
*GROUP TGHIS GAMB, 1987, CANCER RES, V47, P5782
[6]  
Low-Beer S, 2000, J ACQ IMMUN DEF SYND, V23, P360
[7]   CONCURRENT AND PREDICTIVE-VALIDITY OF A SELF-REPORTED MEASURE OF MEDICATION ADHERENCE [J].
MORISKY, DE ;
GREEN, LW ;
LEVINE, DM .
MEDICAL CARE, 1986, 24 (01) :67-74
[8]   Adherence to protease inhibitor therapy and outcomes in patients with HIV infection [J].
Paterson, DL ;
Swindells, S ;
Mohr, J ;
Brester, M ;
Vergis, EN ;
Squier, C ;
Wagener, MM ;
Singh, N .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (01) :21-30
[9]  
PRADIER C, 2002, 9 C RETR OPP INF SEA
[10]   Cue-dose training with monetary reinforcement - Pilot study of an antiretroviral adherence intervention [J].
Rigsby, MO ;
Rosen, MI ;
Beauvais, JE ;
Cramer, JA ;
Rainey, PM ;
O'Malley, SS ;
Dieckhaus, KD ;
Rounsaville, BJ .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2000, 15 (12) :841-847